[Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis]

Minerva Chir. 1994 Nov;49(11):1077-82.
[Article in Italian]

Abstract

From June 1989 to December 1991, 93 patients affected by malignant pleural effusion (MPE) were treated as out patients using a ultrasound (US) guided catheter drainage (10F Percuflex pig-tail catheter-Medi-tech@(PTC) and chemical pleurodesis. The PTC was positioned when the MPE had been diagnosed by X-ray and all the patients had undergone some thoracentesis (mean 3.2, range 2-6). We started a chemical pleurodesis when the MPE was inferior to 100cc/day injecting Epidoxorubicin (EDX 30 mg/mq) in the pleural space on alternate day for three administrations, and then, a lyophilized Corynebacterium Parvum (Wellcome strain CN 6134) (CBP 14 mg) on alternate day for two administrations. The complete response rate of this treatment was 90% (86 pt) with a mean treatment period of 32.9 days (range 12-62). Complete response was assessed as total resolution of pleural effusion. Side effects were short-term hyperpyrexia in 65 cases (69.8%) and pleurodynia in 15 cases (15.7%). Three patients (3.1%) were complicated by a pleural infection which was resolved in 1 case and became chronic in 2. These findings indicate that this technique is an adequate treatment for the control of MPE inducing a clinical and quality-life improvement.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / complications
  • Catheterization
  • Drainage / instrumentation*
  • Epirubicin / administration & dosage
  • Female
  • Humans
  • Lung Neoplasms / complications
  • Male
  • Mesothelioma / complications
  • Middle Aged
  • Pleural Effusion, Malignant / etiology
  • Pleural Effusion, Malignant / surgery
  • Pleural Effusion, Malignant / therapy*
  • Pleural Neoplasms / complications
  • Pleurodesis*
  • Propionibacterium acnes

Substances

  • Epirubicin